Search

everythinglearnresearchcommunity

for

Search:↓

Innate lymphoid cells type 1 may contribute to alopecia areata.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Combined therapy effectively improved severe alopecia areata in all patients after 6 months.

Alopecia areata in infants may be more common than previously thought.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Dietary changes and supplements mostly did not improve alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Two siblings both had a rare case of alopecia areata at the same time.

Hair transplants can temporarily help with eyebrow hair loss.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.